Israel Englander’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

Israel Englander’s Portfolio SHAC Stock Details SHAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,096,208	Closed	-$10.8M	–	7559
2022 Q3	$10.8M	Buy	1,096,208 +366,828	+50%	+$3.62M	0.01%	2030
2022 Q2	$7.17M	Hold	729,380	–	–	﹤0.01%	2418
2022 Q1	$7.13M	Buy	729,380 +100,614	+16%	+$982K	﹤0.01%	2542
2021 Q4	$6.16M	Buy	628,766 +92,428	+17%	+$902K	﹤0.01%	2682
2021 Q3	$5.22M	Buy	536,338 +480,850	+867%	+$4.65M	﹤0.01%	2815
2021 Q2	$537K	Buy	+55,488	New	+$539K	﹤0.01%	5250

Israel Englander's SHAC Position: Q4 2022 in Review

Israel Englander sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q4 2022, closing a stake of 1,096,208 shares — an estimated $10.8M sold.

Israel Englander first reported a position in SHAC in Q2 2021 and held it in 6 quarters. The position peaked at $10.8M in Q3 2022. 0 funds tracked by Wall St. Rank hold SHAC as of Q4 2022.

Israel Englander reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Israel Englander sold 1,096,208 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q4 2022, an estimated $10.8M.
Israel Englander first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q2 2021 and held it in 6 quarters.
Israel Englander's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $10.8M in Q3 2022.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.